TKNO — Alpha Teknova, Inc.
$6.42+4.39%
Last close: · regular session
After-hours $6.33 -1.40% ·
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for TKNO in the TickerWise workspace.
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
Company profile
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: US
- Exchange: NASDAQ
- Employees: 173
- Website: https://www.teknova.com
Latest SEC filings for TKNO
Latest TKNO news
- Alpha Teknova (TKNO) Stock Jumps 5.1%: Will It Continue to Soar? Read article
- Alpha Teknova prices $40M stock offering at $5 per share Read article
- Alpha Teknova reports Preliminary Q3 results Read article
- All You Need to Know About Alpha Teknova (TKNO) Rating Upgrade to Buy Read article
- Head-To-Head Survey: Alpha Teknova (NASDAQ:TKNO) and Icon (NASDAQ:ICLR) Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.